Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Square Brussels Convention Centre

Mar 12, 2024 9:00 AM - Mar 14, 2024 4:00 PM

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

Africa Townhall - Operationalization of AMA: Building an Equitable, Sustainable Regulatory Ecosystem Across Africa

Session Chair(s)

Sarah  Adam

Sarah Adam

Associate Director, Regulatory Affairs

IFPMA, Switzerland

Martin  Harvey Allchurch, LLM

Martin Harvey Allchurch, LLM

Head of International Affairs

European Medicines Agency, Netherlands

This session will offer a platform for dialogue on the operationalization of AMA and will discuss proposals on improved collaboration in Africa on regulatory harmonisation and convergence, application of reliance pathways and digitalisation. As efforts on the African continent are concentrated on accelerating the operationalization of the African Medicines Agency (AMA), it is important to consider and leverage the experience and learnings from mature regulatory agencies such as EMA and international work-sharing schemes like WHO CRP, EUM4All, Swissmedic MAGHP and ACCESS Consortium. As a new, modern regulatory agency, AMA has the potential to establish a robust and unique regulatory framework to address gaps and inconsistencies in the national regulatory systems in the regions as well as optimize technical capabilities, regulatory expertise,? and digital tools to drive efficient and sustainable regulatory operations at the continental level. Great strides have been made in enhancing regulatory harmonization and convergence in Africa via the Africa Medicines Regulatory Harmonization initiative and its partnership platform and the Regional Economic Communities' (RECs) implementation of several joint assessment procedures (JAPs) (e.g., EAC, ZAZIBONA and ECOWAS).? The need to strengthen harmonisation of other parts of the registration is also imperative. To further enhance collaboration and work-sharing, it is imperative that AMA considers lessons learnt from the various regional JAPs and international regulatory work-sharing procedures. Given the positive impact of digitalization, it is vital that AMA implements digital tools, to drive efficiencies in its operations and provides the utmost benefits to all stakeholders in the regulatory ecosystem, especially patients.? This session will highlight regional and international experiences from joint assessment procedures, and how these can uplift the Africa regulatory ecosystem including advancing maturity of several national regulatory agencies and RECs in Africa. The session will also cover the adoption of digitization initiatives on the continent and offer a platform for engagement and dialogue on optimizing the AMA operationalization.?

Learning Objective : Progress made on AMA operationalization including the achievements so far with the support of partners Insights and learnings drawn from EMA OPEN, EUM4All, Swissmedic MAGHP, WHO CRP  and ACCESS Consortium as AMA operationalization progresses  The way forward to implement a sustainable regulatory ecosystem in Africa (vision 2030) encompassing good regulatory practice and work sharing practices

Speaker(s)

Chimwemwe  Chamdimba

Progress in Africa Medicines Regulatory Harmonisation: Continental Pilot, IMS, Capacity Building Activities Engagement with RECs and NRAs

Chimwemwe Chamdimba

African Union Development Agency-NEPAD, South Africa

African Medicines Regulation Harmonization Programme Head

Gugu Nolwandle Mahlangu, MBA, MSc

Panelist

Gugu Nolwandle Mahlangu, MBA, MSc

Zimbabwe

Sybil Nana Ama  Ossei-Agyeman-Yeboah

Panelist

Sybil Nana Ama Ossei-Agyeman-Yeboah

West African Health Organisation (WAHO), Burkina Faso

Professional Officer in Charge, Essential Medicines and Vaccines

Samvel  Azatyan, MD, PhD

Panelist

Samvel Azatyan, MD, PhD

World Health Organization (WHO), Switzerland

Team Lead, Regulatory Convergence and Networks (RCN/REG)

Zainab  Aziz, MSc, RPh

Panelist

Zainab Aziz, MSc, RPh

Novartis, South Africa

Associate Director-RA Policy and Strategic Operations SSA

David  Mukanga, PhD, MPH

Panelist

David Mukanga, PhD, MPH

Bill & Melinda Gates Foundation, United States

Deputy Director, Africa Regulatory Systems

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.